Grow your business safely with ANTIBODY TECHNOLOGIES

All the information you need about ANTIBODY TECHNOLOGIES to develop and secure your business in France

A HOME > CORPORATES > ANTIBODY TECHNOLOGIES > BALANCE SHEET ( 2021-08-11)

THE LIST OF BALANCE SHEET : ANTIBODY TECHNOLOGIES

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2021-08-11 Public 2020-12-31 Simplified
2020-08-05 Public 2019-12-31 Simplified
2019-07-02 Public 2018-12-31 Simplified
NameANTIBODY TECHNOLOGIES
Siren534174909
Closing2020-12-31
Registry code 6752
Registration number 11220
Management number2011B01804
Activity code 6420Z
Closing date n-12019-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2021-08-11
Modification00 Annual accounts entered without anomaly
Balance sheet typeS : Simplified
Currency codeEUR
ConfidentialityPublic
Address67206 Mittelhausbergen
1 - Assets and liabilities (balance sheet) Gross amount NAmortization year NNet year NNet year N-1
040 Financial Assets 50 000.00 50 000.00 50 000.00
044 Total Fixed Assets 50 000.00 50 000.00 50 000.00
084 Cash 586.00 586.00 586.00
096 Total Current Assets + Prepaid Expenses 586.00 586.00 586.00
110 Total Assets 50 586.00 50 586.00 50 586.00
120 Share or Individual Capital 51 000.00
134 Retained Earnings -2 977.00
136 Profit for the Year -6.00
142 Total Equity - Total I 48 017.00
166 Suppliers and related accounts 660.00
169 Other debts including current accounts of partners for fiscal year N 1 908.00
172 Other debts 1 908.00
176 Total debts 2 568.00
180 Liabilities Total 50 586.00
2 - Income statementAmount year NAmount year N-1
217 Production of services sold - Export 700.00 700.00
218 Production of services sold - France 700.00 700.00
232 Total operating income excluding VAT 700.00 700.00
242 Other external expenses 706.00 706.00
264 Total operating expenses 706.00 706.00
270 Operating profit -6.00 -6.00
310 Profit or loss -6.00 -6.00

all companies in France

Complete and comprehensive database.